A real-world prospective observational multi-national study in adult patients with breast cancer treated with extended adjuvant neratinib: NERLYFE study

被引：0
|
作者：
Harbeck, N. [1 ]
Jegannathen, A. [2 ]
Schmidt, M. [3 ]
Tsalic, M. [4 ]
Baerens, D. -T. [5 ]
Baschar, Y. [6 ]
Davies, M. [7 ]
Abdulkhalek, H. [8 ]
Smakal, M. [9 ]
Beghdad, F. [10 ]
Castagne, C. [10 ]
Zivanov, M. [10 ]
Bartsch, R. [11 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Dept Gynecol & Obstet, Ctr Comprehens Canc, Breast Ctr, Munich, Germany
[2] Univ Hosp North Midlands NHS Trust, Dept Oncol, Stoke On Trent, Staffs, England
[3] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany
[4] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[5] Gynako Onkolog Praxis, Ilsede, Germany
[6] Brustzentrum Stadt Kliniken Monchengladbach, Monchengladbach, Germany
[7] Singleton Hosp, Swansea, W Glam, Wales
[8] Western Hlth Social Care Trust, Med Oncol Dept, Londonderry, North Ireland
[9] Nemocnice Horovice, Onkol Oddeleni, Horovice, Czech Republic
[10] Pierre Fabre, Boulogne, France
[11] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria
来源：
BREAST | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P009
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [21] First interim analysis from ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor positive (HER2+) early breast cancer observing real-life extended adjuvant treatment with neratinib
    Luftner, Diana
    Bartsch, Rupert
    Breitenstein, Urs
    Balic, Marija
    Jackisch, Christian
    Muller, Volkmar
    Rinnerthaler, Gabriel
    Schmidt, Marcus
    Schwitter, Michael
    Zaman, Khalil
    Wrobel, Denise
    Guth, Dagmar
    Terhaag, Jurgen
    Zaiss, Matthias
    Schinkothe, Timo
    Harbeck, Nadia
    CANCER RESEARCH, 2022, 82 (04)
  • [22] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [23] TREATMENT SATISFACTION OF GUSELKUMAB FOR PLAQUE PSORIASIS PATIENTS IN A MULTI-NATIONAL, REAL-WORLD SETTING
    Molaei, M.
    Yang, F.
    Fitzgerald, T.
    Piercy, J.
    Lucas, J.
    Teneralli, R.
    VALUE IN HEALTH, 2022, 25 (12) : S479 - S479
  • [24] Extended adjuvant treatment of patients with HER2+early breast cancer with neratinib: a multi-centric, prospective, noninterventional study (NIS) in Germany and Austria (ELEANOR)
    Bartsch, R.
    Lueftner, D.
    Balic, M.
    Rinnerthaler, G.
    Jackisch, C.
    Mueller, V.
    Schmidt, M.
    Harbeck, N.
    BREAST, 2021, 56 : S18 - S18
  • [25] How breast cancer recurrences are found - a real-world, prospective cohort study
    Myller, Sylvia
    Jukkola, Arja
    Jaaskelainen, Anniina
    Roininen, Nelli
    Karihtala, Peeter
    ACTA ONCOLOGICA, 2022, 61 (04) : 417 - 424
  • [26] How breast cancer recurrences are found? A real-world, prospective cohort study
    Myller, S.
    Jukkola, A.
    Jaaskelainen, A.
    Roininen, N.
    Karihtala, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S81 - S82
  • [27] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    NEUROLOGICAL SCIENCES, 2023, 44 (07) : 2455 - 2463
  • [28] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Hyoung Cheol Lee
    Soohyun Cho
    Byung-Kun Kim
    Neurological Sciences, 2023, 44 : 2455 - 2463
  • [29] Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study
    Gyenes, G
    Fornander, T
    Carlens, P
    Glas, U
    Rutqvist, LE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (04): : 899 - 905
  • [30] Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy
    Telli, Tugba Akin
    Ozturk, Mehmet Akif
    Alan, Ozkan
    Hasanov, Rahib
    Kostek, Osman
    Arikan, Rukiye
    Basoglu, Tugba
    Kaya, Serap
    Ercelep, Ozlem
    Babacan, Nalan Akgul
    Dane, Faysal
    Yumuk, Perran Fulden
    FUTURE ONCOLOGY, 2022, 18 (22) : 2425 - 2439
12345